Scholarly Works per year
Scholarly Works per year
Fingerprint
Dive into the research topics where Rachna Shroff is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
ACR Appropriateness Criteria® Staging and Follow-Up of Primary Liver Cancer
Expert Panel on Gastrointestinal Imaging, Nov 2025, In: Journal of the American College of Radiology. 22, 11, p. S699-S712Research output: Contribution to journal › Article › peer-review
Open Access -
A First-in-Human Study of Cinrebafusp Alfa, a HER2/4-1BB Bispecific Molecule, in Patients with HER2-Positive Advanced Solid Malignancies
Piha-Paul, S., Olwill, S. A., Hamilton, E., Tolcher, A., Pohlmann, P., Liu, S. V., Wurzenberger, C., Hasenkamp, L. C., Hansbauer, E. M., Shroff, R., Hurvitz, S., Krishnamurthy, A., Patnaik, A., Hahn, N., Kumar, R., Duerr, M., Zettl, M., Aviano, K., Matis, L. & Bruns, I. & 1 others, , Jan 15 2025, In: Clinical Cancer Research. 31, 2, p. 288-298 11 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
A model for decoding resistance in precision oncology: acquired resistance to FGFR inhibitors in cholangiocarcinoma
Goyal, L., DiToro, D., Facchinetti, F., Martin, E. E., Peng, P., Baiev, I., Iyer, R., Maurer, J., Reyes, S., Zhang, K., Majeed, U., Berchuck, J. E., Chen, C. T., Walmsley, C., Pinto, C., Vasseur, D., Gordan, J. D., Mody, K., Borad, M. & Karasic, T. & 35 others, , Apr 2025, In: Annals of Oncology. 36, 4, p. 426-443 18 p.Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations -
Anti–PD-1 Therapy for Patients with Advanced Cholangiocarcinoma: Ready for Prime Time?
Brar, G. & Shroff, R. T., May 2025, In: Journal of Immunotherapy and Precision Oncology. 8, 2, p. 181-183 3 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
A phase III randomized study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancer
Knox, J. J., McNamara, M. G., Bazin, I. S., Oh, D. Y., Zubkov, O., Breder, V., Bai, L. Y., Christie, A., Goyal, L., Cosgrove, D. P., Springfeld, C., Sjoquist, K. M., Park, J. O., Verdaguer, H., Braconi, C., Ross, P. J., De Gramont, A., Shroff, R. T., Zalcberg, J. R. & Palmer, D. H. & 4 others, , Aug 2025, In: Journal of Hepatology. 83, 2, p. 358-366 9 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations
Grants
-
Enhancing NCI-funded research at the University of Arizona Cancer Center
Shroff, R. (PI)
Project: Research project
-
DNA methylation, Liquid Biopsy, and Pancreatic Cancer
Nelson, M. A. (PI), Futscher, B. W. (CoPI) & Shroff, R. (CoPI)
Project: Research project
Datasets
-
Epidemiologic patterns of biliary tract cancer in the United States: 2001–2015
Koshiol, J. (Creator), Yu, B. (Creator), Kabadi, S. M. (Creator), Baria, K. (Creator) & Shroff, R. T. (Creator), figshare, 2022
DOI: 10.6084/m9.figshare.c.6306479, https://springernature.figshare.com/collections/Epidemiologic_patterns_of_biliary_tract_cancer_in_the_United_States_2001_2015/6306479
Dataset
-
Additional file 2 of Epidemiologic patterns of biliary tract cancer in the United States: 2001–2015
Koshiol, J. (Creator), Yu, B. (Creator), Kabadi, S. M. (Creator), Baria, K. (Creator) & Shroff, R. T. (Creator), figshare, 2022
DOI: 10.6084/m9.figshare.21582644, https://springernature.figshare.com/articles/dataset/Additional_file_2_of_Epidemiologic_patterns_of_biliary_tract_cancer_in_the_United_States_2001_2015/21582644
Dataset
-
Liquid biopsy, using a novel DNA methylation signature, distinguishes pancreatic adenocarcinoma from benign pancreatic disease
Vrba, L. (Creator), Futscher, B. W. (Creator), Oshiro, M. (Creator), Watts, G. S. (Creator), Menashi, E. (Creator), Hu, C. (Creator), Hammad, H. (Creator), Pennington, D. R. (Creator), Golconda, U. (Creator), Gavini, H. (Creator), Roe, D. J. (Creator), Shroff, R. T. (Creator) & Nelson, M. A. (Creator), figshare, 2022
DOI: 10.6084/m9.figshare.c.5855943.v1, https://springernature.figshare.com/collections/Liquid_biopsy_using_a_novel_DNA_methylation_signature_distinguishes_pancreatic_adenocarcinoma_from_benign_pancreatic_disease/5855943/1
Dataset
-
Liquid biopsy, using a novel DNA methylation signature, distinguishes pancreatic adenocarcinoma from benign pancreatic disease
Vrba, L. (Creator), Futscher, B. W. (Creator), Oshiro, M. (Creator), Watts, G. S. (Creator), Menashi, E. (Creator), Hu, C. (Creator), Hammad, H. (Creator), Pennington, D. R. (Creator), Golconda, U. (Creator), Gavini, H. (Creator), Roe, D. J. (Creator), Shroff, R. T. (Creator) & Nelson, M. A. (Creator), figshare, 2022
DOI: 10.6084/m9.figshare.c.5855943, https://springernature.figshare.com/collections/Liquid_biopsy_using_a_novel_DNA_methylation_signature_distinguishes_pancreatic_adenocarcinoma_from_benign_pancreatic_disease/5855943
Dataset
-
Treatment options for biliary tract cancer: unmet needs, new targets and opportunities from both physicians' and patients' perspectives
Shroff, R. T. (Creator) & Bachini, M. (Creator), Taylor & Francis, 2024
DOI: 10.6084/m9.figshare.26935920, https://tandf.figshare.com/articles/dataset/Treatment_options_for_biliary_tract_cancer_unmet_needs_new_targets_and_opportunities_from_both_physicians_and_patients_perspectives/26935920
Dataset